Journal of pain and symptom management
-
J Pain Symptom Manage · Feb 2024
Psychometric Properties of the Japanese Version of the Edmonton Functional Assessment Tool 2.
Physical symptoms such as pain and cancer-related fatigue limit physical function and activities of daily living among patients with terminal cancer, which can lead to a decline in quality of life. Therefore, comprehensive functional impairments should be evaluated to determine the progression of the disease and the effectiveness of palliative treatment. ⋯ These results indicate that the EFAT2-J has robust psychometric properties and is useful for evaluating physical function in patients with terminal cancer, and thus may be an acceptable clinical instrument in research and practice.
-
J Pain Symptom Manage · Feb 2024
Transdermal rotigotine at end-of-life for Parkinson's disease: association with measures of distress.
End-of-life (EOL) care for Parkinson's disease (PD) can be challenging when oral medications are no longer tolerated. ⋯ Rotigotine dose and admission LEDD were both associated with proxy measures of distress in the last 72 hours of life. This suggests cautious use of rotigotine at EOL. LEDD may help identify patients at risk of distress. Rates of inappropriate prescribing and symptom prevalence were high, indicating a need for further staff education to optimize the care of PWP.
-
J Pain Symptom Manage · Feb 2024
Multicenter Study Controlled Clinical TrialNursing care for spiritual pain in terminal cancer patients: A non-randomized controlled trial.
Spiritual well-being is important for terminal cancer patients; however, appropriate interventions remain to be established. ⋯ SpiPas-SCP-N for spiritual pain may have a positive impact on terminal cancer patients. Future research using larger samples, randomized design, and the meaning/peace subscale of FACIT-Sp as the primary outcome is necessary as well as supervision and continuous training in daily nursing practice.
-
J Pain Symptom Manage · Feb 2024
Case ReportsRoutine Monitoring of QTc Interval as a Barrier for Efficient Use of Methadone in Palliative Care.
Methadone is a commonly prescribed opioid amongst cancer patients. It has unique pharmacological properties which can benefit in treating complex pain syndromes and neuropathic pain. However, strict guidelines have been created in a generalized manner for chronic pain and long-term survival patients. These guidelines, such as QT interval monitoring can lead to limitations for methadone use in patients with comfort-associated goals. We present two cases of patients with metastatic cancer who were treated for pain with methadone and had to undergo opioid rotation due to abnormal QT intervals. ⋯ In the palliative care setting, monitoring QTc per chronic pain guidelines may lead to uncontrolled pain and a significant impact on quality of life.